Yuh-Min Chiang
Chief Technology OfficerMr. Yuh-Min Chiang, also known as Johnson, Ph. D., serves as Chief Technology Officer at Insight Molecular Diagnostics Inc. (formerly known as OncoCyte Corporation) and served as its Senior Vice President, R&D and Product Development since 2023. He served as Chief Technology Officer at Insight Molecular Diagnostics Inc. (formerly known as OncoCyte Corporation) from May 2023 to 2023 and was its Senior Vice President of R&D and Product Development from February 2023 until May 2023. He joined Oncocyte Corporate in September 2021. Prior to joining Oncocyte, he holds the Chief Technology Officer in Alveo Technologies, an IVD company focusing on development of cutting edge molecular diagnostic tests for Over The Counter (OTC) and Point-Of-Care (POC) applications. he led the teams to develop the COVID-19 be. well Test for a successful US clinical trial and obtained the CE mark and UK approval. Before Alveo Technologies, he was the Head of Systems Integration & Molecular Biology at Foundation Medicine, Inc. and held senior management positions at Life Technologies and Thermo Fisher Scientific where he led systems design, integration, verification and validation for qPCR and next-generation sequencing platforms, including Oncomine Dx Target Test as the very first NGS-based CDx test approved by FDA. He also worked at Cepheid where he oversaw a few key product developments from the concept to commercialization under FDA regulation. He has extensive experience and successful track records in product development (device, instrument, SW and assays) as well as design control for PMA applications. He also owns several patents and published numerous biotechnology papers. He holds a Ph.D. degree focused on BioMEMS (Micro Electro-Mechanical Systems) from University of California, Irvine. He received his Master in Engineering from The Ohio State University and Bachelor of Applied Chemistry from National Chiao Tung University, Taiwan.
公司職務
- 公司名稱Insight Molecular Diagnostics Inc.股票代碼IMDX職務Chief Technology Officer共事同僚
- JRJoshua RiggsPresident, CEO & Director
- AAAndrew ArnoIndependent Chairman
- ASAndrea Susan JamesChief Financial Officer
- JLJames LiuVP of Accounting, Treasurer, Controller & Principal Accounting Officer
- ESEkkehard SchutzChief Science Officer
- AJAndrew J. LastIndependent Director
- LELouis E. SilvermanIndependent Director
- DRDavid R. GandaraMember of Scientific & Medical Advisory Board
